Availability of data and materials
All data generated in this study are included in the main manuscript.
References
Rollig C, Knop S, Bornhauser M (2015) Multiple myeloma. Lancet 385(9983):2197–2208. https://doi.org/10.1016/s0140-6736(14)60493-1
Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387(10038):2641–2654. https://doi.org/10.1016/s0140-6736(15)01274-x
Nasr SH, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Lacy M, Dispenzieri A, Rajkumar SV, Kyle RA, Leung N (2012) Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am J Kidney Dis 59(6):786–794. https://doi.org/10.1053/j.ajkd.2011.12.028
Zagouri F, Kastritis E, Symeonidis AS, Giannakoulas N, Katodritou E, Delimpasi S, Repousis P, Terpos E, Dimopoulos MA, Greek Myeloma Study G (2014) Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents. Eur J Haematol 92(4):308–312. https://doi.org/10.1111/ejh.12255
Hogan JJ, Alexander MP, Leung N (2019) Dysproteinemia and the kidney: core curriculum 2019. Am J Kidney Dis 74(6):822–836. https://doi.org/10.1053/j.ajkd.2019.04.029
Doshi M, Lahoti A, Danesh FR, Batuman V, Sanders PW, American Society of Nephrology Onco-Nephrology F (2016) Paraprotein-related kidney disease: kidney injury from paraproteins-what determines the site of injury? Clin J Am Soc Nephrol CJASN 11(12):2288–2294. https://doi.org/10.2215/CJN.02560316
Funding
This work was supported by the National Natural Science Foundation of China (grant No.81470956) and CAMS Innovation Fund for Medical Sciences (2019-I2M-5–046). The funders had no role in study design, data collection and analysis, interpretation of the data, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Z.S.L wrote the manuscript and collected clinical data; X.J.Y collected the histopathological images; A.B.Q and M.Y.L collected the clinical follow-up date. S.X.W collected the histopathological images and corrected the manuscript; F.D.Z designed the research and corrected the manuscript; M.H.Z contributed essential reagents and tools. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethics approval
This study was performed in accordance with the Helsinki Declaration, and approved by the ethics committee of the Peking University First Hospital. Written informed consent was obtained from the patient.
Consent for publication
Informed written consent was obtained from the patient for publication of this case report and accompanying images. A Copy of the written consent is available for review by the Editor of this journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lin, ZS., Yu, XJ., Qin, AB. et al. Coexistent light chain deposition disease, light chain cast nephropathy, and vascular light chain amyloidosis in a patient with IgD lambda multiple myeloma. Int Urol Nephrol 53, 1729–1731 (2021). https://doi.org/10.1007/s11255-020-02744-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02744-z